Aktieselskabet Schouw & Co.
14.8.2026 08:01:00 CEST | Globenewswire | Press release
Schouw & Co. raises its full-year 2026 guidance on revenue and EBITDA
Schouw & Co. raises its full-year 2026 guidance on revenue and EBITDA
Schouw & Co. will today be releasing its interim report for the second quarter of 2026. The interim report contains inside information, as the guidance for full-year revenue and EBITDA differs from the guidance expressed in the company’s interim report for the first quarter of 2026 released on 1 May 2026.
Schouw & Co. increases its guidance for FY 2026 consolidated revenue to the range of DKK 34.8-37.2 from previously DKK 33.0-35.5 billion. At the same time, the guidance for FY 2026 consolidated EBITDA is raised to the range of DKK 3,150-3,350 million from previously DKK 2,900-3,200 million.
The upgraded guidance is based on the Board of Directors’ and the Executive Management’s assessment of the outlook for the Group’s businesses for the rest of the year, including the information on BioMar’s guidance in company announcement no. 45 of 12 August 2026.
The company’s full interim report for the second quarter of 2026 will be released immediately following this message.
Aktieselskabet Schouw & Co.
Jørgen Wisborg, Chairman of the Board of Directors
Jens Bjerg Sørensen, President & CEO
Please direct any questions to President Jens Bjerg Sørensen, telephone no. +45 86 11 22 22.
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Brookfield Corporation21.9.2026 23:15:00 CEST | Press release
Brookfield Corporation Announces Pricing of $600 Million Notes Due 2031
Azerion Group NV21.9.2026 18:02:48 CEST | Press release
Azerion Group N.V. Publishes bond prospectus and applies for admission to trading of its bonds on Nasdaq Stockholm
F. Hoffmann-La Roche Ltd21.9.2026 17:45:00 CEST | Press release
European Commission approves Roche’s Susvimo® for the treatment of neovascular age-related macular degeneration (nAMD)
Cority Software Inc.21.9.2026 17:24:28 CEST | Press release
Cority Named a Leader in 2026 Verdantix Green Quadrant for EHS Software for Seventh Consecutive Year
Unlimit Group A/S21.9.2026 17:07:14 CEST | Pressemeddelelse
Unlimit Group A/S: Ledende medarbejders og disses nærtstående transaktioner med Unlimit-aktier
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom